ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 354437 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 354437; 2) Community: the network communities that were significantly associated with the response to NSC 354437; 3) Molecule: the relationships between components within communities and NSC 354437; 4) MDR: the compounds that were significantly associated with the NSC 354437.

NSC Compound Enrichment Correlation
NSC 698931 Null 0.0107933723273943 0.45293424
NSC 708782 Null 0.0107933723273943 0.29900194
NSC 714680 Null 0.0107933723273943 0.44965739
NSC 732122 2-[3-(Benzothiazol-2-ylsulfanyl)-3-(4-methoxy-phenyl)-allyli dene]-malononitrile 0.0107933723273943 0.21462901
NSC 748896 Null 0.0107933723273943 0.033334028
NSC 751382 N-(3-((2,5-dimethylbenzyl)oxy)-4-(N-methylmethylsulfonamido)phenyl)-2,3-dihydro-1H-indene-5-carboxamide 0.0107933723273943 0.29709485
NSC 758357 2-oxo-N-(pyridin-4-yl)-2-(1-tosyl-1H-indol-3-yl)acetamide 0.0107933723273943 0.32573553
NSC 169774 Bromocriptine methanesulfonate 0.0112113991710615 0.34690476
NSC 317908 Null 0.0112113991710615 0.24059472
NSC 348121 4,6-Methano-5H-benz[h]oxazolo[3,2-a]pyrazino-[3,2,1-de][1,5]naphthyridine-7-carbonitrile, 1,2,3a,4,4a,6,7,9,10,13,13b,13c-dodecahydro-9-(hydroxymethyl)-11-methoxy-5,12-dimethyl-10,13-dioxo- 0.0112113991710615 0.17883099
Total:106  Current:34    [First] [Prev] [Next] [Last]